Back

ANDAMAN - Aspirin twice a day and Acute Coronary Syndrome

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Trials: cardiovascular risk and prevention Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Jean-Guillaume Dillinger

Hospital Lariboisiere, Paris (France)

3 More presentations in this session

Presentation thumbnail
Biomarker-guided risk management following acute coronary syndromes
Professor R. Doughty (Auckland, NZ)
Slides Video
Presentation thumbnail
CAC CV-PREVITAL Coronary Artery Calcium Scoring in primary prevention
Doctor G. Ferrante (Milan, IT)
Slides Video
Presentation thumbnail
CONFIDENCE: ambulatory blood pressure monitor substudy
Doctor M. Vaduganathan (Boston, US)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Trials: cardiovascular risk and prevention
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
PANTHER - P2Y12 inhibitor or Aspirin moNoTHERapy as secondary prevention in patients with coronary artery disease
thumbnail
Congress Presentation
Aspirin reloading before percutaneous coronary intervention on chronic aspirin therapy: reduced early ischemia without bleeding trade-off
thumbnail
Congress Presentation
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources